How to Help Your Patients Find Estring in Stock: A Provider's Guide

Patients on Estring (estradiol vaginal ring) in 2026 are frequently encountering pharmacy stock issues. As a prescriber, you are often the first person patients call when they can't fill their prescription — and the guidance you provide in those moments significantly impacts whether they maintain their therapy or experience a gap in treatment. This guide provides practical, actionable strategies for helping your patients navigate Estring availability challenges.

Why Your Patients Are Struggling to Find Estring

Estring was listed on the ASHP official drug shortage database in February 2024 due to manufacturing delays at Pfizer, its sole manufacturer. While the listing was updated to "available" in May 2024, pharmacy-level stock has remained unpredictable for several reasons:

No generic exists — there is no backup manufacturer if Pfizer production slips

The broader HRT demand surge following the FDA's November 2025 removal of the systemic HRT black box warning increased demand across all estrogen products

Many retail pharmacies stock Estring in small quantities — a single local surge in demand can deplete a pharmacy's supply before the next wholesaler delivery

Step 1: Recommend medfinder for Pharmacy Stock Checking

The most practical tool you can recommend to patients is medfinder. Patients enter their medication, dosage, and location, and medfinder calls pharmacies near them to check which ones can fill the prescription — then texts the results. This eliminates the frustrating loop of patients calling your office every time they can't locate their medication.

Step 2: Proactively Write Early Refill Prescriptions

Because Estring is not a controlled substance, there are no DEA restrictions on when you can write a new prescription. Encourage patients on Estring to request a new prescription around the 75-day mark — two weeks before the ring is due for replacement. This provides a buffer to locate stock without experiencing a treatment gap.

Some prescribers in shortage-affected regions have begun routinely writing two rings at a time (a 6-month supply) to further buffer against stock disruptions. Check your state pharmacy laws and insurance plan rules regarding days supply limits before doing this.

Step 3: Build a Standing Bridge Prescription Protocol

Consider creating a standing protocol in your practice for Estring patients who report stock difficulties: automatically generate a bridge prescription for estradiol vaginal tablets 10 mcg (Vagifem or generic) when a patient reports they cannot find Estring within 5 business days of needing it. This keeps patients on therapy while they continue searching for Estring.

This approach avoids unnecessary phone tag and prevents the most common outcome of a shortage: patients going weeks without therapy because they don't want to bother their provider with what feels like a minor complaint.

38,518+ patients found their medications in stock

38K+

Find Estring In Stock Today →

Step 4: Identify Local Specialty and Compounding Pharmacies

Independent and compounding pharmacies near your practice are valuable resources during shortages. They often:

Stock specialty items that large chains don't prioritize

Can special-order Estring within 2–5 business days if a patient brings a valid prescription

Can compound a vaginal estradiol formulation if commercial Estring is truly unavailable

Having 2–3 local specialty pharmacies in your referral network — and sharing their contact information with your care coordinators — can significantly speed up resolution for patients in shortage situations.

Step 5: Counsel Patients on the Full Landscape of Vaginal Estrogen Options

Many patients don't realize that several effective alternatives exist. Taking time at the initial Estring prescription visit to explain the alternatives — and note them in the patient's chart as "acceptable substitutes" — allows your staff to act quickly without requiring another provider visit when a shortage occurs.

Consider documenting something like: "If Estring unavailable, may substitute: estradiol vaginal tablet 10 mcg 2x/week OR estradiol vaginal cream 1 g 2x/week — patient counseled on all three options."

Skip the calls, skip the stress.

Find Estring In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Step 6: Insurance and Prior Authorization Considerations

When switching patients to an alternative, check their formulary tier for each option. Generic estradiol vaginal tablets are usually Tier 1–2 on most commercial plans and are typically much less expensive than brand-name Estring. If switching from Estring to a brand-name alternative (Premarin, Imvexxy), your patient may face a different tier or require a new prior authorization.

Pfizer offers a savings card for Estring through their menopause savings program, reducing out-of-pocket cost to as little as $25/fill for commercially insured patients. Inform patients of this card so cost isn't an additional barrier when they do locate Estring in stock.

Key Takeaways for Your Practice

Recommend medfinder.com to patients to efficiently locate pharmacies with Estring in stock

Issue refill prescriptions 2 weeks early to buffer against stock gaps

Establish a standing bridge prescription protocol for when patients cannot locate Estring

Build a list of local specialty pharmacies that can special-order or compound vaginal estrogen

Document acceptable alternatives in the patient chart at the time of the initial Estring prescription

Remind patients of the Pfizer savings card (as low as $25/fill for commercially insured patients)